|
Market Closed -
Other stock markets
|
After market 07:41:09 pm | |||
| 724.9 USD | -1.00% |
|
727.3 | +0.33% |
| Apr. 25 | Scholz pledges further support for the pharmaceutical industry | DP |
| Apr. 25 | Scholz promises support for pharma sector in Germany as Merck invests | RE |
Jan 27 (Reuters) - Eli Lilly and Co said on Friday the U.S. health regulator approved its drug for the treatment of a rare form of blood cancer.
The Food and Drug Administration gave accelerated approval to Jaypirca for the treatment of adults mantle cell lymphoma after at least two lines of therapy. (Reporting by Leroy Leo in Bengaluru; Editing by Maju Samuel)
| 1st Jan change | Capi. | |
|---|---|---|
| +24.35% | 653B | |
| +24.17% | 556B | |
| -6.33% | 354B | |
| +19.90% | 331B | |
| +7.95% | 296B | |
| +13.45% | 233B | |
| +6.04% | 201B | |
| -10.51% | 193B | |
| -12.26% | 143B | |
| -6.47% | 144B |
ELI LILLY AND COMPANY 
